 |
|
Obesity may be erythropoietin dose-saving in hemodialysis patients
Ghada M. El-Kannishy, Abir F. Megahed, Mona M. Tawfik, Ghada El-Said, Rabab T. Zakaria, Nahed A. Mohamed, Eman M. Taha, Alzhraa A. Ammar, Abeer M. Abd Eltawab, Nagy A. Sayed-Ahmed
Kidney Res Clin Pract. 2018;37(2):148-156. Published online 2018 Jun 30 DOI: https://doi.org/10.23876/j.krcp.2018.37.2.148
|
|
Citations to this article as recorded by
 Pharmacokinetics of Nivolumab and Erythropoietin in a Rat Model of Diet-Induced Obesity
Yi-Hua Sheng, Celine Park, Yae Eun Chong, Christine Yohn, Anna Siemiątkowska, Katarzyna Kosicka-Noworzyń, Amrit Kaur, Karan Sapra, Luigi Brunetti, Leonid Kagan
Pharmaceutical Research.2025; 42(2): 271. CrossRef Serum erythropoietin in acute ischemic stroke: preliminary findings
Lisda Amalia, Gilang Nispu Saputra
Scientific Reports.2024;[Epub] CrossRef Prevalence and risk factors of erythropoiesis stimulating agents hyporesponsiveness in chronic hemodialysis patients attending nephrology center of Benghazi
Mohamed Ezwaie, Ragheda Ezwaie, Sarah Younis, Seraj Elfigih
Libyan Journal of Medical Research.2024; 18(1): 112. CrossRef Assessment criteria to diagnose malnutrition (undernutrition and overnutrition) in haemodialysis patients
Ghumayra Aziz, Zarina Ebrahim, Nazeema Esau, Meseret M. Bazezew
Journal of Renal Nutrition.2024;[Epub] CrossRef Severe Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients on Chronic Hemodialysis—Reconsidering the Relationship with Thrombo-Inflammation and Oxidative Stress
Srdjan Nikolovski, Branislava Medic Brkic, Katarina Savic Vujovic, Ivana Cirkovic, Nina Jovanovic, Bhavana Reddy, Omer Iqbal, Chongyu Zhang, Jawed Fareed, Vinod Bansal
Diagnostics.2024; 14(21): 2406. CrossRef Is metabolic‐dysfunction‐associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo‐responsiveness among patients with end‐stage kidney disease on haemodialysis?
Wei‐Kei Wong, Wah‐Kheong Chan, Shubash Ganapathy, Soo‐Kun Lim
Nephrology.2023; 28(8): 425. CrossRef Associations of obesity and body shape with erythrocyte and reticulocyte parameters in the UK Biobank cohort
Sofia Christakoudi, Konstantinos K. Tsilidis, Evangelos Evangelou, Elio Riboli
BMC Endocrine Disorders.2023;[Epub] CrossRef Individualization of the Dosage Regimen of Erythropoietin is Crucial in End-stage Renal Disease Patients
M. K. Krishnapriya, S. Karthika, Anisha Babu, Antriya Annie Tom
Saudi Journal of Kidney Diseases and Transplantation.2023; 34(5): 474. CrossRef Investigation of the Relationship between Lean Muscle Mass and Erythropoietin Resistance in Maintenance Haemodialysis Patients: A Cross-Sectional Study
Wen-Fang Chiang, Po-Jen Hsiao, Kun-Lin Wu, Hung-Ming Chen, Chi-Ming Chu, Jenq-Shyong Chan
International Journal of Environmental Research and Public Health.2022; 19(9): 5704. CrossRef Factors contributing to the recovery from anemia in hemodialysis patients during the administration of recombitant erythropoietin
Tanja Boljević, Damir Peličić
Zdravstvena zastita.2022; 51(3): 66. CrossRef Responsiveness to an erythropoiesis-stimulating agent is correlated with body composition in patients undergoing chronic hemodialysis
Hyang Yun Lee, Suk-Won Suh, Jin Ho Hwang, Jungho Shin
Frontiers in Nutrition.2022;[Epub] CrossRef Phase angle values, a good indicator of nutritional status, are associated with median value of hemoglobin rather than hemoglobin variability in hemodialysis patients
Do Hyoung Kim, Dong-Jin Oh
Renal Failure.2021; 43(1): 327. CrossRef Relationship between Cardiac Geometry and Serum Hepcidin in Chronic Kidney Disease: Analysis from the KNOW-CKD Study
Hyang Ki Min, Yun Kyu Oh, Kyu Hun Choi, Kyu Beck Lee, Sue K. Park, Curie Ahn, Sung Woo Lee
Journal of Korean Medical Science.2020;[Epub] CrossRef Erythropoiesis and Red Cell Indices Undergo Adjustments during Pregnancy in Response to Maternal Body Size but not Inflammation
Rodrigo Vega-Sánchez, Mari Cruz Tolentino-Dolores, Blanca Cerezo-Rodríguez, Georgette Chehaibar-Besil, María Eugenia Flores-Quijano
Nutrients.2020; 12(4): 975. CrossRef Use of erythropoiesis-stimulating agents in obese hemodialysis patients
Sun-Hee Park
Kidney Research and Clinical Practice.2018; 37(3): 308. CrossRef The authors' reply
Ghada M. El-Kannishy
Kidney Research and Clinical Practice.2018; 37(3): 310. CrossRef
|